Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output.

Mihai Gheorghiade*, Andrew P. Ambrosy, Mara Ferrandi, Patrizia Ferrari

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output.'. Together they form a unique fingerprint.

Medicine & Life Sciences